DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Breaks Above Fifty Day Moving Average - Here's What Happened

DENTSPLY SIRONA logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • DENTSPLY SIRONA shares rose above their 50-day moving average, reaching $9.96 before closing near $9.90 on volume of roughly 6.1 million shares.
  • Analyst sentiment remains cautious: the stock has a consensus “Hold” rating, with three Buys, eight Holds and three Sells, while several firms recently lowered their price targets. The average target is $12.62.
  • The company’s latest quarterly results beat expectations, reporting $0.52 in EPS versus a $0.35 estimate and $898 million in revenue, though revenue declined 4.1% year over year and net margins remained negative.
  • MarketBeat previews the top five stocks to own by December 1st.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) crossed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $9.68 and traded as high as $9.96. DENTSPLY SIRONA shares last traded at $9.90, with a volume of 6,060,465 shares changing hands.

Wall Street Analyst Weigh In

XRAY has been the subject of several research reports. Leerink Partners decreased their price target on shares of DENTSPLY SIRONA from $14.00 to $10.00 and set a "market perform" rating for the company in a research note on Wednesday, October 14th. Weiss Ratings reissued a "sell (e+)" rating on shares of DENTSPLY SIRONA in a research note on Friday. BMO Capital Markets dropped their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating on the stock in a research note on Thursday, September 17th. Mizuho cut their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating on the stock in a report on Thursday, October 22nd. Finally, Piper Sandler decreased their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating for the company in a research note on Friday, October 9th. Three equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $12.62.

Check Out Our Latest Report on XRAY

DENTSPLY SIRONA Price Performance

The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The firm has a fifty day moving average price of $9.68 and a two-hundred day moving average price of $11.33. The stock has a market capitalization of $1.97 billion, a P/E ratio of -3.60, a P/E/G ratio of 1.21 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.17. The firm had revenue of $898.00 million during the quarter, compared to analyst estimates of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. DENTSPLY SIRONA's quarterly revenue was down 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently made changes to their positions in XRAY. CenterBook Partners LP raised its holdings in shares of DENTSPLY SIRONA by 46.8% during the third quarter. CenterBook Partners LP now owns 49,760 shares of the medical instruments supplier's stock valued at $441,000 after purchasing an additional 15,858 shares during the last quarter. Villanova Investment Management Co lifted its position in DENTSPLY SIRONA by 13.4% during the third quarter. Villanova Investment Management Co now owns 191,770 shares of the medical instruments supplier's stock valued at $1,699,000 after purchasing an additional 22,660 shares during the period. Commonwealth Equity Services LLC boosted its holdings in DENTSPLY SIRONA by 13.5% in the third quarter. Commonwealth Equity Services LLC now owns 1,800,822 shares of the medical instruments supplier's stock worth $15,955,000 after purchasing an additional 213,988 shares during the last quarter. Bfsg LLC boosted its holdings in DENTSPLY SIRONA by 13.4% in the third quarter. Bfsg LLC now owns 22,230 shares of the medical instruments supplier's stock worth $197,000 after purchasing an additional 2,620 shares during the last quarter. Finally, Chicago Partners Investment Group LLC grew its position in DENTSPLY SIRONA by 1,130.7% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 266,884 shares of the medical instruments supplier's stock worth $2,517,000 after purchasing an additional 245,199 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines